Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3
about
EQ-5D in Central and Eastern Europe: 2000-2015.The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey.
P2860
Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@ast
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@en
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@nl
type
label
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@ast
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@en
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@nl
prefLabel
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@ast
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@en
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@nl
P2093
P2860
P1476
Impact of imiglucerase supply ...... ts with Gaucher disease type 3
@en
P2093
Cecilia Kämpe Björkvall
Hans Hägglund
Joanna Wieremiejczyk
Kristina Myhr-Eriksson
Martin Paucar Arce
Per Svenningsson
P2860
P2888
P356
10.1007/S00005-014-0308-8
P577
2014-09-10T00:00:00Z
P5875
P6179
1040140448